Indan Journal of Medical Research Indan Journal of Medical Research Indan Journal of Medical Research Indan Journal of Medical Research
  Home About us Editorial board Search Ahead of print Current issue Archives Submit article Instructions Subscribe Contacts Login  
  Home Print this page Email this page Small font sizeDefault font sizeIncrease font size Users Online: 900       

   Table of Contents      
CLINICAL IMAGES
Year : 2016  |  Volume : 144  |  Issue : 1  |  Page : 143

Zosteriform type in-transit metastasis of melanoma


Institute of Oncology, University of Istanbul, Istanbul, Turkey

Date of Web Publication3-Nov-2016

Correspondence Address:
Faruk Tas
Institute of Oncology, University of Istanbul, Istanbul
Turkey
Login to access the Email id

Source of Support: None, Conflict of Interest: None


DOI: 10.4103/0971-5916.193304

Rights and Permissions

How to cite this article:
Tas F. Zosteriform type in-transit metastasis of melanoma. Indian J Med Res 2016;144:143

How to cite this URL:
Tas F. Zosteriform type in-transit metastasis of melanoma. Indian J Med Res [serial online] 2016 [cited 2020 Dec 1];144:143. Available from: https://www.ijmr.org.in/text.asp?2016/144/1/143/193304

A 69 yr old male with a history of melanoma with painless papulonodular lesions on the left side of trunk presented to the Institute of Oncology, University of Istanbul, Turkey, for further management in November 2014. Three months earlier, he had a melanoma located on the superior-medial part of his back excised, treated with wide-surgical excision plus sentinel lymph node biopsy, followed by radical dissection of left axillary lymph nodes. A PET/CT also showed bone metastasis. After one cycle of single-agent temozolomide chemotherapy, multiple papulonodular lesions developed extending from the adjacent to the site of melanoma excision to homolateral sternal region, with a typical zosteriform distribution along the dermatomes [Figure 1]. Serology and PCR investigations for varicella-zoster virus (VZV) were negative and no history of previous VZV infection was known.The BRAF (V600E) positive patient was treated with vemurafenib, an oral selective BRAF inhibitor. A significant clinical response was obtained within a few weeks.
Figure 1. A typical zosteriform distribution along the dermatomes as in-transit melanoma metastasis (arrows)


Click here to view



    Figures

  [Figure 1]



 

Top
 
 
  Search
 
    Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
    Access Statistics
    Email Alert *
    Add to My List *
* Registration required (free)  

 
  In this article
    Article Figures

 Article Access Statistics
    Viewed731    
    Printed6    
    Emailed0    
    PDF Downloaded175    
    Comments [Add]    

Recommend this journal